Innovate (Innovate) Total Liabilities : $1,116.70 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Innovate Total Liabilities?

Innovate's Total Liabilities for the quarter that ended in Mar. 2024 was $1,116.70 Mil.

Innovate's quarterly Total Liabilities declined from Sep. 2023 ($1,231.30 Mil) to Dec. 2023 ($1,195.30 Mil) and declined from Dec. 2023 ($1,195.30 Mil) to Mar. 2024 ($1,116.70 Mil).

Innovate's annual Total Liabilities increased from Dec. 2021 ($1,136.80 Mil) to Dec. 2022 ($1,242.30 Mil) but then declined from Dec. 2022 ($1,242.30 Mil) to Dec. 2023 ($1,195.30 Mil).

Innovate Total Liabilities Historical Data

The historical data trend for Innovate's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovate Total Liabilities Chart

Innovate Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

6,514.70

6,123.60

1,136.80

1,242.30

1,195.30

Innovate Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,162.20	1,207.60	1,231.30	1,195.30	1,116.70

Innovate Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Innovate's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	413.8	+	(727.9	+	49.5
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	4.1	+	0)
	=	1,195.30

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1043.6	-	-151.7
	=	1,195.30

Innovate's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	349	+	(688.3	+	75.2
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	4.2	+	0)
	=	1,116.70

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	943.5	-	-173.2
	=	1,116.70

Innovate Total Liabilities Related Terms

Thank you for viewing the detailed overview of Innovate's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovate (Innovate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Innovate Corp (OTCPK:HCCDZ.PFD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

VATE:USA PSTA:Germany

Address

295 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

https://www.innovatecorp.com

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.